Patent · US Active

Methods for treating juvenile arthritis with ant-bile salt-stimulated lipase (BSSL) antibodies

US9168299B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

LIPUM AB · SE

Inventors

Olle Hernell · Umeå, SE
Susanne Lindquist · Röbäck, SE
Lennart Gustav Lundberg · Lindome, SE

Key dates

Filing date	Oct 30, 2013
Grant date	Oct 27, 2015
Priority date	—
Expiry date	Oct 30, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.